Acarbose 100 MG Oral Tablet — RxCUI 199150
RxNorm drug concept · Semantic clinical drug
RxCUI 199150
Semantic clinical drug · SCD
● Current RxNorm concept 15 FDA products
30 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI199150
Official nameAcarbose 100 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped15
Package NDCs mapped30
Reported Medicaid activity (SDUD)39,489 prescriptions · 40 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Acarbose: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Acarbose works in your gut — it blocks enzymes that break down carbohydrates into sugar, which slows how fast glucose gets into your blood after you eat. That's why timing matters...
- What exactly does acarbose do, and why do I need to take it with meals?
- By itself, acarbose does not cause low blood sugar — that's actually one of its advantages. However, if you're also taking a sulfonylurea or insulin alongside acarbose, the combina...
- Will I get low blood sugar (hypoglycemia) from acarbose?
🕸️ Concept Web — How Acarbose 100 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Acarbose 100 MG Oral Tablet
RxCUI 199150 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Acarbose
16681IN
-
Acarbose
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Precose
151826BN
-
Precose
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Acarbose Oral Tablet
370504SCDF -
Acarbose Oral Product
1153649SCDG -
Acarbose Pill
1153650SCDG -
Acarbose Oral Tablet [Precose]
368300SBDF -
Precose Oral Product
1185237SBDG -
Precose Pill
1185238SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Acarbose Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Acarbose 100 MG
315246SCDC -
Acarbose 100 MG Oral Tablet [Precose]
209248SBD -
Acarbose 100 MG [Precose]
569872SBDC
-
Acarbose 100 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Acarbose 100 MG
SCDC · 315246 -
Acarbose Oral Tablet
SCDF · 370504 -
Acarbose Oral Product
SCDG · 1153649 -
Acarbose Pill
SCDG · 1153650
Brand-Name Concepts
-
Acarbose 100 MG Oral Tablet [Precose]
SBD · 209248 -
Acarbose 100 MG [Precose]
SBDC · 569872 -
Acarbose Oral Tablet [Precose]
SBDF · 368300 -
Precose Oral Product
SBDG · 1185237 -
Precose Pill
SBDG · 1185238 -
Precose
BN · 151826
📦 FDA Products & Package NDCs
15 products · 30 package NDCs
30 package NDCs map to RxCUI 199150 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00054-0140-25 | 100 TABLET in 1 BOTTLE (0054-0140-25) | Acarbose | Hikma Pharmaceuticals USA Inc. | 2008-05-07 |
| 00054-0141-25 | 100 TABLET in 1 BOTTLE (0054-0141-25) | Acarbose | Hikma Pharmaceuticals USA Inc. | 2008-05-07 |
| 00054-0142-25 | 100 TABLET in 1 BOTTLE (0054-0142-25) | Acarbose | Hikma Pharmaceuticals USA Inc. | 2008-05-07 |
| 23155-0147-01 | 100 TABLET in 1 BOTTLE (23155-147-01) | Acarbose | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2021-04-16 |
| 23155-0147-05 | 500 TABLET in 1 BOTTLE (23155-147-05) | Acarbose | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2021-04-16 |
| 23155-0147-10 | 1000 TABLET in 1 BOTTLE (23155-147-10) | Acarbose | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2021-04-16 |
| 23155-0148-01 | 100 TABLET in 1 BOTTLE (23155-148-01) | Acarbose | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2021-04-16 |
| 23155-0148-05 | 500 TABLET in 1 BOTTLE (23155-148-05) | Acarbose | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2021-04-16 |
| 23155-0148-10 | 1000 TABLET in 1 BOTTLE (23155-148-10) | Acarbose | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2021-04-16 |
| 23155-0149-01 | 100 TABLET in 1 BOTTLE (23155-149-01) | Acarbose | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2021-04-16 |
| 23155-0149-05 | 500 TABLET in 1 BOTTLE (23155-149-05) | Acarbose | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2021-04-16 |
| 23155-0149-10 | 1000 TABLET in 1 BOTTLE (23155-149-10) | Acarbose | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2021-04-16 |
| 62135-0453-90 | 90 TABLET in 1 BOTTLE (62135-453-90) | Acarbose | Chartwell RX, LLC | 2023-01-31 |
| 62135-0454-90 | 90 TABLET in 1 BOTTLE (62135-454-90) | Acarbose | Chartwell RX, LLC | 2023-01-31 |
| 62135-0455-90 | 90 TABLET in 1 BOTTLE (62135-455-90) | Acarbose | Chartwell RX, LLC | 2023-01-31 |
| 64380-0758-06 | 100 TABLET in 1 BOTTLE, PLASTIC (64380-758-06) | Acarbose | Strides Pharma Science Limited | 2016-12-08 |
| 64380-0759-06 | 100 TABLET in 1 BOTTLE, PLASTIC (64380-759-06) | Acarbose | Strides Pharma Science Limited | 2016-12-10 |
| 64380-0760-06 | 100 TABLET in 1 BOTTLE, PLASTIC (64380-760-06) | Acarbose | Strides Pharma Science Limited | 2016-12-10 |
| 72789-0131-01 | 100 TABLET in 1 BOTTLE, PLASTIC (72789-131-01) | Acarbose | PD-Rx Pharmaceuticals, Inc. | 2026-06-24 |
| 72789-0131-30 | 30 TABLET in 1 BOTTLE, PLASTIC (72789-131-30) | Acarbose | PD-Rx Pharmaceuticals, Inc. | 2023-07-07 |
| 72789-0131-60 | 60 TABLET in 1 BOTTLE, PLASTIC (72789-131-60) | Acarbose | PD-Rx Pharmaceuticals, Inc. | 2020-10-21 |
| 72789-0131-90 | 90 TABLET in 1 BOTTLE, PLASTIC (72789-131-90) | Acarbose | PD-Rx Pharmaceuticals, Inc. | 2022-09-16 |
| 72789-0132-01 | 100 TABLET in 1 BOTTLE, PLASTIC (72789-132-01) | Acarbose | PD-Rx Pharmaceuticals, Inc. | 2026-06-24 |
| 72789-0132-30 | 30 TABLET in 1 BOTTLE, PLASTIC (72789-132-30) | Acarbose | PD-Rx Pharmaceuticals, Inc. | 2023-07-07 |
| 72789-0132-60 | 60 TABLET in 1 BOTTLE, PLASTIC (72789-132-60) | Acarbose | PD-Rx Pharmaceuticals, Inc. | 2020-10-21 |
| 72789-0132-90 | 90 TABLET in 1 BOTTLE, PLASTIC (72789-132-90) | Acarbose | PD-Rx Pharmaceuticals, Inc. | 2022-09-16 |
| 72789-0133-01 | 100 TABLET in 1 BOTTLE, PLASTIC (72789-133-01) | Acarbose | PD-Rx Pharmaceuticals, Inc. | 2026-06-24 |
| 72789-0133-30 | 30 TABLET in 1 BOTTLE, PLASTIC (72789-133-30) | Acarbose | PD-Rx Pharmaceuticals, Inc. | 2023-07-07 |
| 72789-0133-60 | 60 TABLET in 1 BOTTLE, PLASTIC (72789-133-60) | Acarbose | PD-Rx Pharmaceuticals, Inc. | 2020-10-21 |
| 72789-0133-90 | 90 TABLET in 1 BOTTLE, PLASTIC (72789-133-90) | Acarbose | PD-Rx Pharmaceuticals, Inc. | 2022-09-16 |
Observed labelers:
PD-Rx Pharmaceuticals, Inc. (12) ·
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. (9) ·
Chartwell RX, LLC (3) ·
Hikma Pharmaceuticals USA Inc. (3) ·
Strides Pharma Science Limited (3)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.